The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Alcoholic Hepatitis Treatment Global Market Report 2023, The global alcoholic hepatitis treatment market is expected to grow from $2.70 billion in 2022 to $2.95 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The alcoholic hepatitis treatment market is expected to reach $3.95 billion in 2027 at a CAGR of 7.6%.

What was the major driver in the alcoholic hepatitis treatment market?
The increased prevalence of liver diseases caused by alcohol consumption is expected to propel the growth of the alcoholic hepatitis treatment market going forward. Alcoholic liver disease is the result of the liver’s function being damaged. The liver performs numerous bodily processes, such as cleansing the blood and generating bile to aid digestion. For instance, in December 2021, according to the National Library of Medicine, a US-based biomedical library run by the federal government, By 2040, it is predicted that an increase in alcohol use of one year during the COVID-19 pandemic will result in 8,000 more cases of alcohol-related liver disease-related deaths, 18,700 cases of liver failure, and 1,000 cases of liver cancer. Compared to 2019, there was a 20.0% increase in the total number of alcohol-related deaths in 2020. Furthermore, in July 2021, according to gov.uk, a UK-based public sector information website, alcohol-related liver fatalities increased by 20.8% between 2019 and 2020, making up 80.3% of all alcohol-related deaths. Therefore, the increased prevalence of liver diseases caused by alcohol is driving the growth of the alcoholic hepatitis treatment market.

View More On The Alcoholic Hepatitis Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/alcoholic-hepatitis-treatment-global-market-report

What was the key trend in the alcoholic hepatitis treatment market?
Product innovations are a key trend gaining popularity in the alcoholic hepatitis treatment market. Companies operating in the alcoholic hepatitis treatment market are focused on innovating new products to sustain their position in the market. For instance, in July 2022, Roche Holding AG, a Switzerland-based healthcare company, launched the Elecsys HCV Duo, an innovative dual antibody and antigen hepatitis C virus diagnostic test. It allows the detection of the hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample independently and simultaneously. The test can be used to identify patients who are recovering or who exhibit symptoms of a chronic infection that may result in other diseases, such as liver cancer, as well as early-stage infections. As core antigen manifests early in the course of infection and is utilized as a sign of ongoing viral replication, the combined detection of HCV’s core antibodies and antigen allows physicians to diagnose active HCV earlier than utilizing antibody-only assays.

Which was the largest region in the alcoholic hepatitis treatment market?
North America was the largest region in the alcoholic hepatitis treatment market in 2022. It is expected to be the fastest-growing region in the forecast period. The regions covered in alcoholic hepatitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the alcoholic hepatitis treatment market prominent players?
Major players in the alcoholic hepatitis treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Sanofi PLC, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Torrent Pharmaceuticals Ltd., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KGaA, Viatris Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca Plc, Cadila Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Mylan Inc., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals, Alkermes PLC, Intercept Pharmaceuticals Inc., Apotex Inc., and Durect Corp.

Key alcoholic hepatitis treatment market segments
The global alcoholic hepatitis treatment market is segmented –
1) By Treatment: Drug Treatment, Stem Cell Therapy
2) By Drug Class: Corticosteroids, Hemorheologic Agents, Monoclonal Antibodies, Anabolic Steroids, Other Drug Classes
3) By Route of Administration: Oral, Injectable
4) By Application: Hospital, Clinic, Private Treatment Center

Request A Sample Of The Global Alcoholic Hepatitis Treatment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12104&type=smp

The Alcoholic Hepatitis Treatment Global Market Report 2023  provides a comprehensive overview on the alcoholic hepatitis treatment market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Hyperphosphatemia Treatment Global Market Report 2023
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2023
Diuretics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model